Back to 
Blackstone Inc.
Blackstone Inc.
IBRX
4 quarters
Position history for Blackstone Inc.'s holdings in ImmunityBio, Inc.
No. Blackstone exited its IBRX (ImmunityBio) position in Q4 2025. Its Q3 2025 13F listed 11,944 shares worth $29,382. Blackstone already held IBRX in its Q1 2021 13F, the earliest on record, and held it in 2 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$1.4M
Total Shares Change
-58,009
Quarter-by-Quarter History
Other major holders of IBRX: BlackRock, Inc., State Street Corp., Vanguard Portfolio Management LLC, Vanguard Capital Management LLC